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Background: About 9% of the offspring of a clinically healthy Piétrain boar named ‘Campus’ showed a progressive
postural tremor called Campus syndrome (CPS). Extensive backcross experiments suggested a dominant mode of
inheritance, and the founder boar was believed to be a gonadal mosaic. A genome-scan mapped the disease-causing
mutation to an 8 cM region of porcine chromosome 7 containing the MHY7 gene. Human distal myopathy type 1
(MPD1), a disease partially resembling CPS in pigs, has been associated with mutations in the MYH7 gene.
Results: The porcine MYH7 gene structure was predicted based on porcine reference genome sequence, porcine
mRNA, and in comparison to the human ortholog. The gene structure was highly conserved with the exception of the
first exon. Mutation analysis of a contiguous genomic interval of more than 22 kb spanning the complete MYH7 gene
revealed an in-frame insertion within exon 30 of MYH7 (c.4320_4321insCCCGCC) which was perfectly associated with the
disease phenotype and confirmed the dominant inheritance. The mutation is predicted to insert two amino acids
(p.Ala1440_Ala1441insProAla) in a very highly conserved region of the myosin tail. The boar ‘Campus’ was shown to be a
germline and somatic mosaic as assessed by the presence of the mutant allele in seven different organs.
Conclusion: This study illustrates the usefulness of recently established genomic resources in pigs. We have identified a
spontaneous mutation in MYH7 as the causative mutation for CPS. This paper describes the first case of a disorder
caused by a naturally occurring mutation in the MYH7 gene of a non-human mammalian species. Our study confirms
the previous classification as a primary myopathy and provides a defined large animal model for human MPD1. We
provide evidence that the CPS mutation occurred during the early development of the boar ‘Campus’. Therefore, this
study provides an example of germline mosaicism with an asymptomatic founder.Background
In 1988, a commercial center for artificial insemination
in southern Germany recognised a number of piglets
affected by a progressive tremor. Those piglets were
identified as being the progeny of a clinically normal
Piétrain boar named ‘Campus’ used for artificial insemin-
ation. Affected pigs started showing clinical signs of the
disorder at 2–9 weeks of age: muscular tremors starting
in the hind limbs followed by tremors in the fore limbs
briefly after. Tremors were present while walking (with
an impaired gait) or standing only and absent at rest
(Additional file 1). The clinical course of the so called
‘Campus’-syndrome (CPS) was progressive and the tre-
mors were more severe in older animals, which became* Correspondence: cord.droegemueller@vetsuisse.unibe.ch
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reproduction in any medium, provided the orquickly exhausted [1,2]. The pigs were highly stress-
susceptible and most of them died from heart attack before
maturity. Muscle fiber degeneration and regeneration as
well as interstitial fibrosis were observed, and this was
associated with primary myopathy [3,4]. Intriguingly,
macroscopic and light microscopic examinations of brain
and peripheral nerves detected no morphological alteration
[2]. In addition, neurophysiological studies with quantita-
tive electromyography did not determine any myopathic
changes and motor nerve conduction velocity appeared to
be unaltered [5].
For further characterization of the disorder, the boar
‘Campus’ was mated with clinically healthy sows of six
different pig breeds [1]. The offspring of matings be-
tween ‘Campus’ and 7 healthy sows showed about 9.3%
(26 out of 270) affected piglets. Both sexes were affected
equally. However, 10 out of 15 of the offspring of three
affected sows showed clinical signs of the syndrome.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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inheritance, where the founder ‘Campus’ was believed to
be a gonadal mosaic [1,5]. Using animals from the back-
cross experiment, a genome-scan with 254 porcine
microsatellite markers across all porcine autosomes was
performed to map the CPS locus to a region of approxi-
mately 8 cM on porcine chromosome (SSC) 7 [1]. At
that time, a comparison of human and pig genome maps
indicated homology to human chromosome (HSA) 15q
and 14q11-q13 which contains the human dominant dis-
tal myopathy type 1 (MPD1) locus [1,6]. Clinical signs of
MPD1 partially resemble CPS and subsequently, myosin
VII (MYH7) gene mutations have been reported to be
associated with MPD1 in humans [7].
The molecular analysis of the functional and positional
candidate gene was hindered by the lack of sequence
data for porcine MYH7. However, availability of the
reference pig genome sequence facilitated the sequen-
cing of the entire porcine MYH7 gene described in this
paper. We identified the CPS causing mutation which
confirmed the suggested dominant mode of inheritance
and the gonadal mosaicism of the founder boar.
Results
As the annotation of the porcine genome is still in pro-
gress, we inferred the porcine MYH7 gene structure
manually in comparison to the corresponding human
MYH7 gene. Using long-range PCRs we sequenced the
whole gene, exons and introns. We characterized the
genomic structure of the porcine MYH7 gene and per-
formed mutation analysis. These analyses indicated thatFigure 1 ‘Campus’ syndrome pedigree (modified from Tammen et al.
numbered pigs. Note that the founder boar “Campus” was not affected. Fo
indicated by asterisk. The genotypes for the RYR1 mutation causing malign
4320_4321insCCCGCC genotypes (ins = insertion, wt = wildtype) are given bthe porcine MYH7 gene consists of 40 exons separated
by 39 introns and spans 22 kb compared to 39 exons
over 21.5 kb in human MYH7 (NCBI build 37.3) due to
an additional untranslated 50-exon in pigs (Additional
file 2: Figure S1). As the current porcine genome assem-
bly (build 10.2) contained a gap including the sequence
of MYH7 intron 19, we submitted the experimentally
derived genomic sequence of 573 bp containing 281 bp
sequence of intron 19, and flanking exon 19 and
20 sequences into the EMBL nucleotide database
(Acc. HE663068). All splice donor/splice acceptor sites
conform to the GT/AG rule. The porcine transcript con-
tains an open reading frame of 5,808 bp encoding a pro-
tein of 1,935 amino acids.
We re-sequenced a contiguous genomic interval of
more than 22 kb spanning the complete MYH7 gene in-
cluding all coding exons in four pigs (Campus, two
affected individuals and a healthy control, Figure 1).
Nine sequence polymorphisms (Additional file 3:
Table S1) were found in the examined pigs as compared
to the MYH7 reference sequence of the pig genome as-
sembly (build 10.2). Only one of these sequence variants,
the six base-pair insertion c.4320_4321insCCCGCC
located in exon 30 of the MYH7 gene (Figure 2), was
perfectly associated with the CPS phenotype in the four
animals (Figure 1). We genotyped all 14 available ani-
mals in the experimental pedigree for this insertion and
found a perfect association of the mutant insertion-allele
with the CPS phenotype. All affected animals were het-
erozygous for the mutant allele and none of the controls
carried this allele (Figure 1). The mutant allele was[1]). DNA samples were available for this study only from 15
ur animals used for re-sequencing and mutation screening are
ant hyperthermia [8] (P = mutation, N = wildtype) and the MYH7 c.
elow the symbols.
Figure 2 Electropherograms of the MYH7 c. 4320_4321insCCCGCC mutation. Representative sequence traces of PCR products amplified
from genomic DNA of 3 pigs with the different genotypes are shown on the right hand side. The presence of the mutation can be directly
visualized by fragment size analysis of a fluorescently labeled PCR product containing the mutation as shown on the left. Note that the mutant
allele with the 6 bp-insertion is present in heterozygous form in ‘Campus’ and in CPS affected piglets at different ratio.
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breeds including wild boars.
The predicted consequence of the in-frame insertion is
an insertion of two amino acids (p.Ala1440_Ala1441ins
ProAla) in a very highly conserved protein region
(Figure 3).Figure 3 Multiple sequence alignment of the MYH7 protein in
the region of the mutation. Note the nearly perfect conservation
of the surrounding protein sequence. The observed mutation in CPS
affected pigs is indicated by additional two residues. Identical
residues are indicated by a point beneath the alignment, while
different amino acids are reported (the methionine in Xenopus laevis
is a very similar aminoacid).Initially, sequencing didn’t show the presence of the
identified mutation in the assumed founder ‘Campus’
(Figure 2). Subsequently, we established a more sensitive
approach using a fluorescently labeled PCR primer and
fragment analysis which showed that the boar clearly
carries the mutant allele at low level in comparison to
the wild type allele (Figure 2). Genotyping of the MYH7
exon 30 mutation in various organs (liver, kidney,
skeletal muscle (hind and fore limb), testicle, epidydimis,
brain stem, and blood) of ‘Campus’ showed the presence
of both the wild type allele and a smaller sized peak for
the mutant allele in all available samples (Figure 2, the
relative area ratio for each organ is reported in Table 1).Table 1 Percentage of mosaicism in different organs in
mosaic boar ‘Campus’
Tissue Percentage of mosaicism
(from area ratio)
Germinal layer
Liver 17.2 Endoderm
Testicle 8.6 Mesoderm, germline
(entodermal)
Blood 3.4 Mesoderm/Mesenchyme
Kidney 6.0 Mesoderm
Hindlimb muscle 5.4 Mesoderm
Forelimb muscle 11.6 Mesoderm
Epidydimis 5.2 Mesoderm
Brain stem 6.6 Neuroectoderm
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nant hyperthermia (MHS) syndrome, is common in Pié-
train pigs. This is an inherited myopathy caused by a
mutation in the RYR1 gene in which skeletal muscle con-
tracture with hypermetabolism and elevation in body
temperature are triggered by stress or experimentally by
inhalational anesthetics and skeletal muscle relaxants [8].
To assess the influence of the RYR1 locus, all animals and
every ‘Campus’ organ sample analyzed in this study have
been tested for the MHS causing RYR1 mutation. Among
the 10 pigs affected with CPS, six were homozygous for the
MHS mutation, one was heterozygous and three were
homozygous for the wild type allele (Figure 1).
Discussion
After successful linkage mapping of the dominantly
inherited CPS mutation, the molecular analysis of the
positional and functional candidate gene MYH7 was
assisted by the availability of the porcine reference gen-
ome sequence. The clustering of two highly similar
genes (MYH6 and MYH7) within the region of interest
made a specific mutation analysis difficult without
proper gene annotation. Therefore, we initially per-
formed a manually generated gene annotation and con-
firmed the high sequence homology between MYH7 and
the neighboring MYH6 gene. The MYH6 gene encodes
the alpha heavy chain subunit of cardiac myosin, and
mutations in MYH6 cause congenital heart muscle
defects in humans [9]. We choose the slow skeletal
muscle fiber myosin heavy chain gene MYH7 gene as
candidate for CPS as it is predominantly expressed in
the fetal skeletal muscle and after birth in skeletal
muscle, MYH7 is expressed specifically in type 1 fibers
[10]. In the heart, it is only switched on under condi-
tions of thyroid hormone depletion / replacement and in
response to physical stress [11]. Van Rooij et al. [11]
showed that adult onset of expression of MYH7 in the
heart is regulated by a microRNA (miRNA 208),
encoded by intron 27 of MYH6, at stress. These findings
point towards MYH7 as candidate gene because several
affected CPS pigs died after stress from a sudden heart
attack.
Mutation analysis for CPS detected a perfect associ-
ation between the 6 bp insertion in exon 30 of MYH7
and the disease phenotype. The insertion (c.4320_43
21insCCCGCC) is predicted to prolong the encoded
protein by the insertion of the two amino acids alanine
and proline (p.Ala1440_Ala1441insProAla). The inser-
tion occurs 60 amino acids before the myomesin binding
domain region of the filament backbone, in the myosin
tail in the C-terminal end of the protein, which has the
purpose of supporting the head in the contraction move-
ment and creates a coiled-coil structure with another
paired myosin molecule (Additional file 2: Figure S1).The insertion occurs in the myosin tail of the MYH7
protein characterized by a stretch of alanines (NAAAA
PAALDKK, the insertion is bolded and underlined). This
protein region is highly conserved across species
(Figure 3). The insertion of proline in a sequence form-
ing a coiled coil very likely explains the observed disease
phenotype. These structures have an important role as
main structural feature known to dimerize myosins to
form the molecular motors of the musclular fiber [12] It
has been pointed out that proline is generally destructive
for the formation of a coiled coil structure [13] both in
the a and d position. Using Marcoil, a software that pre-
dicts existence and location of potential coiled-coil
domains in protein sequences [14,15], we observed that
in comparison to the wild type, the insertion we
observed caused a drop to zero of the probability of for-
mation of the coiled coil, suggesting a disruptive effect
of the mutation. Furthermore, additional effects of the
mutation on the overall structure of the coil (after the
heptad is shifted by two amino acids) cannot be
excluded. In a helical coiled-coil, residues in a and d
position are typically hydrophobic and create a seam
along the interface of the coiled-coil, whereas residues in
the e and g positions interact electrostatically to stabilize
the coiled-coil. Residues in the outer positions such as b, c,
and f are typically charged and mediate the interactions be-
tween coiled-coils. Blair et al. (2002) pointed out that for
some of the disease causing mutations the pathomechan-
ism might be due to disruption of interactions with other
sarcomeric proteins and complexes and not just due to
changes to the coiled coil structure itself [16]. The myosin
head alone is sufficient to generate force in the fiber [17].
Mutations in the coiled coil could cause a defect in the
transmission of force to the thick filament array. They
could either affect assembly of the thick filament or stabil-
ity of the protein [18]. See Additional file 4: Figure S2,
Additional file 5: FigureS3, and Additional file 6: Table S2
for further details.
In both human MPD1 and porcine CPS, the disease al-
lele is dominant. When comparing the porcine MYH7 mu-
tation causing CPS to known Laing early onset distal
myopathy (MPD1) causing mutations in humans, a proper
assessment of the structure-function relationship of MYH7
mutations remains challenging: there is no clear associ-
ation between the position of the mutation and resulting
pathological effects. Mutations at different positions in the
MYH7 gene can lead to the same disease, however, muta-
tions in the same position have been associated with differ-
ent diseases [19-23]. Mutations affecting the coiled coil are
reported to cause HMC, dilated cardiomyopathy (DCM),
LVNC, and MPD1 [17] (Figure 1B).
The position of the mutation compared to human
reports could seem slightly “off-target” compared to
human reports: The range of the MPD1 associated
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1500 and 1729 of MYH7 encoded by MYH7 exons 32 to
36 [20]. Nevertheless, cases of MPD1 caused by muta-
tions out of this range are reported, as an example in
MYH7 exon 40 [24], or a case of distal myopathy caused
by a MYH7 exon 16 mutation in the head of myosin
showing associated cardiomyopathy [25].
Another factor worthy of consideration is the chemical
properties of the amino acids inserted. Meredith et al.
(2004) compared the nature of mutations in HCM and
MPD1, and pointed out that mutations associated with
HCM had no significant effect on the probability of
coiled coil formation, whereas for MPD1 it was evident
in all the mutations studied had some disruptive effect
on the coiled coil formation [7]. These results suggest
that the observed clinical heterogeneity of human dis-
eases caused by MYH7 mutations in the myosin rod
could be related to different effects on stability of the
mutant MYH7 residue [26]. For example, two independ-
ent MYH7 exon 32 mutations affecting the same amino
acid (R1500P and R1500W) cause different diseases [26].
The proline substitution causes MPD1 and seems to not
alter the coiled coil structure, but to heavily destabilize it
with greater decrease in filament stability. On the other
hand, the tryptophan substitution causes HCM and
shows a greater decrease in thermodynamic stability. In
the same paper, the authors provide a possible explan-
ation for the etiology of different clinical signs and dis-
eases, suggesting that different mutations can lead to
different destiny of the altered fiber in cardiac or skeletal
muscle and hence explain the possibility of lack of HCM
symptoms in MPD1 patients and vice versa [11,26].
The CPS causing mutation in exon 30 affects the myosin
tail domain of porcine MYH7. It can be assumed that the
insertion causes a disruption of the myosin function, and
this would suggest that CPS is similar to human MPD1 in
regards of the disease pathomechanism. Furthermore, the
early onset, the weakness in the hip and shoulder muscles
in the affected pigs (Additional file 1), as well the lack of in-
crease in creatine kinase are similar to most forms of
human MPD1 [2,21]. In addition, the progressive tremor
in CPS affected pigs resembles the reported progressive
weakness in MPD1 patients [27]. The low life expectancy
of pigs affected by CPS could be related to human HCM,
which is a cause of sudden death in otherwise normal indi-
viduals. Several mutations located in exon 30 of human
MYH7 lead to HCM [16]. However, hearts of pigs affected
by CPS showed no cardiac hypertrophy [2]. A possible
background effect of the RYR1 genotype on stress suscepti-
bility in CPS affected pigs has been ruled out. There is not
association between RYR1 mutation and the phenotype, as
well with the piglet low life expectancy (Figure 1). There-
fore, we suggest that the detected MYH7 mutation fully
explains the disease phenotype in the CPS affected piglets.We suggest that ‘Campus’ is confirmed as a founder mo-
saic, as it was shown for ‘Solid Gold’ for ovine callipyge
[28] In fact, as in the case of ‘Solid Gold’, genotyping of 21
autosomal microsatellites markers pointed out no presence
of three or four alleles for ‘Campus’, so we excluded micro-
chimerism. On the other hand, in regard of the specific
mutation, the genetic analysis of different organs from
‘Campus’ showed that the mutant MYH7 allele is present
in all analyzed samples at variable levels ranging from 3.4
to 17.2% (Table 1). These results revealed that ‘Campus’ is
a gonadal and somatic mosaic. With regard to the observed
variability between organs, it is relevant to notice that the
examined organs contain a full set of different tissues. As
an example brain neurons and glial cells develop from the
neuroectoderm, but the brain as such also contains blood
vessels of mesenchymal origin and minute amounts of
connective tissue - along the vessels. Similarly, hepatocytes
are derived from the entoderm but the liver also contains
connective tissue and blood vessels. Thus in the assays,
one would always end up with a mixture of tissues from
different embryonic origin. Hence is it possible that differ-
ent sampling could lead to different results because of a
granularity of the mosaicism recognizable with other meth-
ods. Germline mosaicism is a relatively frequent mechan-
ism in the origin of genetic disorders [29]. Depending on
various factors, such as the gene involved and/or the de-
gree of mosaicism, the carrier of somatic and germline mo-
saicism may be asymptomatic or may present with various
symptoms of the disease [29]. There are two possibilities
for the existence of such a mosaicism: one is that the muta-
tion occurs in a germ cell that continues to divide. The
other possibility is that the mutation occurs very early in a
somatic cell before the separation to germinal cells and is
therefore present both in somatic and germinal cells [29].
This seems to be the most likely explanation for the situ-
ation of ‘Campus’ as he carries the mutant allele in somatic
and germinal cells, although he didn’t show clinical signs
like the affected offspring.
Conclusions
This study elucidates the molecular basis of a spontaneous
lethal mutation initially detected by commercial pig bree-
ders. Unraveling the mutation was facilitated by the largely
improved genomic resources in pigs. This paper describes
the first case of a skeletal muscular disorder caused by a
naturally occurring mutation in the MYH7 gene of a non-
human mammalian species. The genetically characterized
porcine CPS phenotype may represent an interesting large
animal model for human MPD1. The dominantly inherited
CPS disorder belongs to the group of cases where mosai-
cism was suspected in one of the asymptomatic parents.
We provide evidence that the mutation event can be
assigned to an early stage before the differentiation of ger-
minal cells during embryonic development.
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Animals
We collected liver tissue samples from 15 members of
the experimental pedigree used for the initial linkage
mapping [1] including the founder boar ‘Campus’, ten
piglets affected with CPS, and four healthy offspring
(Figure 1). In addition, for ‘Campus’ we collected tissue
samples of kidney, skeletal muscle (hind, and fore limb),
testicle, epidydimis, brain stem, and EDTA stabilized
blood. Furthermore, we sampled genomic DNA of 88
unrelated male control pigs from eight different breeds
(Duroc (n = 1), Husumer (n = 1), Landrace (n = 1), Large
White (n = 1), Meishan (n = 1), Pietrain (n = 9), Swiss
Landrace (n =66), Wild boar (n = 9)) for the genotyping
of the MYH7 exon 30 insertion. We genotyped the RYR1
mutation associated with malignant hyperthermia in pigs
as described previously [8].
All animal work has been conducted according to the
national and international guidelines for animal welfare.
There is no permit number as this study is not based on
an invasive animal experiment. Pigs were slaughtered at
commercial abattoirs for sample collection; there was no
“animal experiment” according to the legal definitions in
Germany.Sequence analysis
The human referenceMYH7mRNA [GenBank: NM_000257]
was used as query in cross-species BLAST searches against
pig genome assembly (build 10.2), porcine mRNA, and EST
sequence databases respectively. A single porcine genomic
SSC 7 contig of 319,923 bp was identified [GenBank:
NW_003610693]. Furthermore, a porcine reference mRNA
sequence of 5,996 bp [GenBank: NM_213855] and a
50UTR containing porcine EST [GenBank: DN132389]
were available. The exact porcine genomic structure was
determined using Spidey [30] and Otterlace [31].Mutation analysis
Genomic DNA was isolated using the DNeasy Blood &
Tissue Kit (Qiagen) according to the manufacturer’s
protocol. Prior to primer design using Primer3 [32] re-
petitive sequences were masked employing Repeatmas-
ker [33]. For the mutation analysis PCR products were
amplified of the founder boar, two affected piglets and a
single normal piglet. PCR products were amplified using
SequalPrep Long PCR Kit (Invitrogen). PCR products
were sequenced on both strands using internal sequen-
cing primers on an ABI 3730 capillary sequencer (Life
Technologies) after treatment with exonuclease I and
shrimp alkaline phosphatase. Sequence data were ana-
lyzed with Sequencher 4.9 (GeneCodes). Fragment size
analyses for the genotyping of the MYH7 exon 30 inser-
tion were also performed on an ABI 3730 capillarysequencer and analyzed with the GeneMapper 4.0 soft-
ware (Applied Biosystems).
Additional files
Additional file 1: Video showing signs of the condition.
Additional file 2: Figure S1. (A) Gene structure of human and porcine
MHY7 gene. The position of the identified CPS mutation is indicated by a
red arrow. (B) Human myosin VII protein and location of known disease
causing mutations within the regions encoded by exons 30 to 32.
Modified from Klaassen et al. [19] (Hypertrophic cardiomyopathy (HCM),
Left ventricular noncompaction (LVNC), dilated cardiomyopathy (DCM),
myosin storage myopathy (MSM), Laing early onset distal myopathy
(MPD1)).
Additional file 3: Table S1. Polymorphisms and genotypes of 4 pigs in
the region of the MYH7 gene.
Additional file 4: Figure S2. Graphical representation of the coiled coil
prediction on the impact of the mutation. (A) wildtype protein (B)
mutant protein. A dramatic drop in probability of the formation of a
coiled coil structure is expected in the latter.
Additional file 5: Figure S3. Position of amino acid in the region of the
MYH7 mutation. (A) Scheme of a generic heptad in a dimeric parallel
coiled coil. Positions in the coil are strictly dictated by the chemical
properties of the residues. Wide, continue red line stands for
hydrophobic interaction, and dotted line for ionic ones. (B) Same
structure in side view (C) Side view of amino acids in the 1431 – p.1454
positions in wildtype as predicted by MARCOIL (D) roles predicted by
MARCOIL for mutant protein (see Additional file 6: Table S2). Is it
expected that the specific pattern regarding the formation of bonds is
disrupted in the specific zone. See [34].
Additional file 6: Table S2. Probability of formation of coiled coil
structure and position assigned to each residue performed by MARCOIL
for the wildtype and mutant MYH7.
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